Trevi Therapeutics, Inc. TRVI Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Trevi Therapeutics, Inc. (TRVI) reported comprehensive income (loss), net of tax, attributable to parent of -$13.53M in Q1 2026.
- How has Trevi Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Trevi Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent decreased by 31.0% year-over-year, from -$10.33M to -$13.53M.
- What is the long-term trend for Trevi Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), Trevi Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent has grown at a 5.9% compound annual growth rate (CAGR), from -$33.94M to -$42.67M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- Measures the total change in equity during a period resulting from transactions and other events from non-owner sources, including net income and other comprehensive income items. It provides a broader view of financial performance than net income alone by incorporating unrealized gains or losses. This metric is essential for understanding the total economic impact on shareholder equity.